Brief: Neovacs Announces Eur 2 Million Capital Increase
June 8 (Reuters) - Neovacs SA ALNEV.PA :
* ANNOUNCES EUR 2 MILLION CAPITAL INCREASE
* NET PROCEEDS OF THIS OPERATION WILL BE USED, FOR 50%, TO
FINANCE
THE KINOÏDE® RESEARCH PROGRAM ON ALLERGIES AND, FOR 50%, TO
STRENGTHEN INVESTMENT CAPACITIES IN PROMISING PROJECTS
* FUNDRAISING OF € 2 MILLION THROUGH THE DRAWDOWN OF 2
TRANCHES OF
OCEANE-BSA, WITH A NOMINAL VALUE OF € 1,000,000
Source text for Eikon: ID:nNDL9FGbG8
Further company coverage: ALNEV.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Neovacs SA
See all newsBrief: Neovacs And FOCH Hospital Commit To Partnership On Research In Pneumology And Allergology
Brief: Neovacs Presented Latest Results On Its Vaccine Candidates Targeting Allergies
Brief: Neovacs H1 Gross Cash Position Down At EUR 6.2 Mln
Brief: Neovacs: Signature Of Trust Agreement For Equitization Of Bonds Redeemable In Shares With Share Warrants
Brief: Neovacs Launches A Public Offering Of Bonds Redeemable In Shares With Stock Warrants